Clinical Trials Directory

Trials / Completed

CompletedNCT03385824

Self-Advocacy for Independent Life (SAIL) After TBI

Self-Advocacy for Independent Life (SAIL) After Traumatic Brain Injury

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Craig Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Traumatic brain injury (TBI) has been conceptualized as a chronic health condition, warranting self-advocacy for health management services across the lifespan. Successful self-advocacy requires a combination of cognitive and communication skills (problem solving, organization, negotiation, etc), which may be impaired following TBI. This project focuses on developing and testing the efficacy of an intervention to enhance self-advocacy skills in individuals who have sustained TBI. This two-arm, randomized controlled trial will include approximately 74 participants, recruited in 4 waves of approximately 18-20 per wave, with each wave recruited from a different geographic area of the state. The primary hypothesis states that participants receiving the treatment intervention will demonstrate significantly greater improvements in self-advocacy beliefs (SAS) from baseline to post-intervention as compared to participants in the control group. Treatment will consist of interactive 4-session workshops along with 2 booster phone calls. Control participants will receive a copy of a self-advocacy workbook after all assessments are completed. Baseline, post-treatment and two follow-up assessments will take place.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSelf-Advocacy for Independent Life (SAIL)SAIL program is based on an interactive workshop model. In -person sessions will focus on: enhancement of self-efficacy beliefs; enhancement of knowledge of TBI self-advocacy information; group process to instill hope and universality; and practice of self-advocacy behaviors in a supportive neuro-rehabilitation structured group environment.

Timeline

Start date
2018-02-01
Primary completion
2020-03-31
Completion
2020-03-31
First posted
2017-12-29
Last updated
2020-07-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03385824. Inclusion in this directory is not an endorsement.